Background: Aspirin reduces risk of colorectal neoplasia in randomized trials and epidemiological studies and inhibits tumor growth and metastases in animal models. However, the influence of aspirin on survival after diagnosis of colorectal cancer is unknown. Methods: Among 1288 participants diagnosed with Stage I, II, or III colorectal cancer enrolled in two cohorts, we used Cox proportional h...